In situ apolipoprotein E-enriched corona guides dihydroartemisinin-decorating nanoparticles towards LDLr-mediated tumor-homing chemotherapy

Li, 2016, Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy, Proc Natl Acad Sci USA, 113, 4164, 10.1073/pnas.1522080113 Kang, 2017, Surface design of magnetic nanoparticles for stimuli-responsive cancer imaging and therapy, Biomaterials, 136, 98, 10.1016/j.biomaterials.2017.05.013 Salvati, 2013, Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface, Nat Nanotechnol, 8, 137, 10.1038/nnano.2012.237 Hadjidemetriou, 2015, In vivo biomolecule corona around blood-circulating, clinically used and antibody-targeted lipid bilayer nanoscale vesicles, ACS Nano, 9, 8142, 10.1021/acsnano.5b03300 Kelly, 2015, Mapping protein binding sites on the biomolecular corona of nanoparticles, Nat Nanotechnol, 10, 472, 10.1038/nnano.2015.47 Ke, 2017, A decade of the protein corona, ACS Nano, 11, 11773, 10.1021/acsnano.7b08008 Lundqvist, 2008, Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts, Proc Natl Acad Sci USA, 105, 14265, 10.1073/pnas.0805135105 Fleischer, 2012, Nanoparticle surface charge mediates the cellular receptors used by protein-nanoparticle complexes, J Phys Chem B, 116, 8901, 10.1021/jp304630q Meena, 2008, Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure in treating hyperlipidemia, Lipids, 43, 231, 10.1007/s11745-007-3142-5 Schottler, 2016, Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers, Nat Nanotechnol, 11, 372, 10.1038/nnano.2015.330 Walkey, 2012, Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment, Chem Soc Rev, 41, 2780, 10.1039/C1CS15233E Nakamura, 2015, Identification of polyethylene glycol-resistant macrophages on stealth imaging in vitro using fluorescent organosilica nanoparticles, ACS Nano, 9, 1058, 10.1021/nn502319r Cruz, 2011, The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells, Biomaterials, 32, 6791, 10.1016/j.biomaterials.2011.04.082 Han, 2015, Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation, J Control Rel, 197, 29, 10.1016/j.jconrel.2014.10.024 Su, 2018, Effects of protein corona on active and passive targeting of cyclic RGD peptide-functionalized PEGylation nanoparticles, Mol Pharm, 15, 5019, 10.1021/acs.molpharmaceut.8b00612 Simon, 2018, Hydrophilicity regulates the stealth properties of polyphosphoester-coated nanocarriers, Angew Chem Int Ed Engl, 57, 5548, 10.1002/anie.201800272 Ma, 2018, Jasmonate promotes artemisinin biosynthesis by activating the TCP14-ORA complex in Artemisia Annua, Sci Adv, 4, eaas9357, 10.1126/sciadv.aas9357 Veerappan, 2013, Differential interactions of the broad spectrum drugs artemisinin, dihydroartemisinin and artesunate with serum albumin, Phytomedicine, 20, 969, 10.1016/j.phymed.2013.04.003 Yang, 2014, Enhanced delivery of artemisinin and its analogues to cancer cells by their adducts with human serum transferrin, Int J Pharm, 467, 113, 10.1016/j.ijpharm.2014.03.044 Mahley, 2009, Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS, J Lipid Res, 50, S183, 10.1194/jlr.R800069-JLR200 Chen, 2005, Apolipoprotein E is required for cell proliferation and survival in ovarian cancer, Cancer Res, 65, 331, 10.1158/0008-5472.331.65.1 Leyva-Gomez, 2015, Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brain, Drug Discov Today, 20, 824, 10.1016/j.drudis.2015.02.009 Zheng, 2005, Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents, Proc Natl Acad Sci USA, 102, 17757, 10.1073/pnas.0508677102 Hosseininasab, 2014, Synthesis, characterization, and in vitro studies of PLGA-PEG nanoparticles for oral insulin delivery, Chem Biol Drug Des, 84, 307, 10.1111/cbdd.12318 Li, 2018, In situ low-immunogenic albumin-conjugating-corona guiding nanoparticles for tumor-targeting chemotherapy, Biomater Sci, 6, 2681, 10.1039/C8BM00692J Fleischer, 2014, Nanoparticle-cell interactions: molecular structure of the protein corona and cellular outcomes, Acc Chem Res, 47, 2651, 10.1021/ar500190q Luiza Andreazza, 2016, Berberine as a photosensitizing agent for antitumoral photodynamic therapy: insights into its association to low density lipoproteins, Int J Pharm, 510, 240, 10.1016/j.ijpharm.2016.06.009 Huntosova, 2012, Development of a new LDL-based transport system for hydrophobic/amphiphilic drug delivery to cancer cells, Int J Pharm, 436, 463, 10.1016/j.ijpharm.2012.07.005 Li, 2016, Evaluation of pharmacokinetics underlies the collaborated usage of lamivudine and oxymatrine in beagle dogs, Asian J Pharm Sci, 11, 641, 10.1016/j.ajps.2016.02.007 Lin, 2016, Blood-brain-barrier-penetrating albumin nanoparticles for biomimetic drug delivery via albumin-binding protein pathways for antiglioma therapy, ACS Nano, 10, 9999, 10.1021/acsnano.6b04268 Hong, 2014, Thermo- and pH-responsive copolymers based on PLGA-PEG-PLGA and poly(L-histidine): synthesis and in vitro characterization of copolymer micelles, Acta Biomater, 10, 1259, 10.1016/j.actbio.2013.12.033 Zhao, 2017, Apolipoprotein E, receptors and modulation of Alzheimer's disease, Biol Psychiatry, 83, 347, 10.1016/j.biopsych.2017.03.003 Thaxton, 2016, Lipoproteins and lipoprotein mimetics for imaging and drug delivery, Adv Drug Deliv Rev, 106, 116, 10.1016/j.addr.2016.04.020 Magro, 2017, Artificial apolipoprotein corona enables nanoparticle brain targeting, Nanomedicine, 14, 429, 10.1016/j.nano.2017.11.008 Schaffler, 2014, Blood protein coating of gold nanoparticles as potential tool for organ targeting, Biomaterials, 35, 3455, 10.1016/j.biomaterials.2013.12.100 Aggarwal, 2009, Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy, Adv Drug Deliv Rev, 61, 428, 10.1016/j.addr.2009.03.009 Kaur, 2017, Developments of polysorbate (Tween) based microemulsions: preclinical drug delivery, toxicity and antimicrobial applications, Int J Pharm, 529, 134, 10.1016/j.ijpharm.2017.06.059 Khan, 2017, Progress in brain targeting drug delivery system by nasal route, J Control Rel, 268, 364, 10.1016/j.jconrel.2017.09.001 Kratz, 2014, A clinical update of using albumin as a drug vehicle - a commentary, J Control Rel, 190, 331, 10.1016/j.jconrel.2014.03.013 He, 2017, Transferrin-inspired vehicles based on pH-responsive coordination bond to combat multidrug-resistant breast cancer, Biomaterials, 113, 266, 10.1016/j.biomaterials.2016.11.001